{
  "accessLevel": "public",
  "bureauCode": [
    "020:00"
  ],
  "contactPoint": {
    "fn": "Jonathan Haselman",
    "hasEmail": "mailto:haselman.jon@epa.gov"
  },
  "description": "These data are represented in tables and graphs in the article, \"Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis\" by JT Haselman et al. \n\nThis dataset is associated with the following publication:\nHaselman, J., J. Olker, P. Kosian, J. Korte, J. Swintek, J. Denny, J. Nichols, J. Tietge, M. Hornung, and S. Degitz. Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis.   TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA,  175(2): 236-250, (2020).",
  "distribution": [
    {
      "downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1504195/Haselman_et_al_2019_data_SciHub.xlsx",
      "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
      "title": "Haselman_et_al_2019_data_SciHub.xlsx"
    }
  ],
  "identifier": "https://doi.org/10.23719/1504195",
  "keyword": [
    "Thyroperoxidase",
    "Xenopus laevis",
    "adverse outcome pathway",
    "thyroid"
  ],
  "license": "https://pasteur.epa.gov/license/sciencehub-license.html",
  "modified": "2019-08-21",
  "programCode": [
    "020:095"
  ],
  "publisher": {
    "name": "U.S. EPA Office of Research and Development (ORD)",
    "subOrganizationOf": {
      "name": "U.S. Environmental Protection Agency",
      "subOrganizationOf": {
        "name": "U.S. Government"
      }
    }
  },
  "references": [
    "https://doi.org/10.1093/toxsci/kfaa036"
  ],
  "rights": null,
  "title": "Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis"
}